No profile data available.
Instil Bio, Inc. (TIL) is a healthcare company in the additional cancer treatment drugs industry, based in Dallas, United States, with about 17 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$71.37 million. Its market capitalization was $45.71 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
Instil Bio reported $0 in revenue for fiscal year 2025.
$45.71 million as of October 9, 2026.
Listed companies of a similar size in the same industry (additional cancer treatment drugs) include Boundless Bio, Inc. (BOLD), Elicio Therapeutics, Inc. (ELTX), Werewolf Therapeutics, Inc. (HOWL), Adlai Nortye Ltd. (ANL).